Translational Medicine Program, The Hospital for Sick Children, Toronto, Ontario, Canada.
Lunenfeld-Tanenbaum Research Institute, Sinai Health, Toronto, Ontario, Canada.
Am J Clin Nutr. 2022 Oct 6;116(4):1038-1048. doi: 10.1093/ajcn/nqac221.
Mechanisms responsible for associations between intake of mother's milk in very-low-birth-weight (VLBW, <1500 g) infants and later neurodevelopment are poorly understood. It is proposed that early nutrition may affect neurodevelopmental pathways by altering gene expression through epigenetic modification. Variation in DNA methylation (DNAm) at cytosine-guanine dinucleotides (CpGs) is a commonly studied epigenetic modification.
We aimed to assess whether early mother's milk intake by VLBW infants is associated with variations in DNAm at 5.5 y, and whether these variations correlate with neurodevelopmental phenotypes.
This cohort study was a 5.5-y follow-up (2016-2018) of VLBW infants born in Ontario, Canada who participated in the Donor Milk for Improved Neurodevelopmental Outcomes trial. We performed an epigenome-wide association study (EWAS) to test whether percentage mother's milk (not including supplemental donor milk) during hospitalization was associated with DNAm in buccal cells during early childhood (n = 143; mean ± SD age: 5.7 ± 0.2 y; birth weight: 1008 ± 517 g). DNAm was assessed with the Illumina Infinium MethylationEPIC array at 814,583 CpGs. In secondary analyses, we tested associations between top-ranked CpGs and measures of early childhood neurodevelopment, e.g., total surface area of the cerebral cortex (n = 41, MRI) and Full-Scale IQ (n = 133, Wechsler Preschool and Primary Scale of Intelligence-IV).
EWAS analysis demonstrated percentage mother's milk intake by VLBW infants during hospitalization was associated with DNAm at 2 CpGs, cg03744440 [myosin XVB (MYO15B)] and cg00851389 [metallothionein 1A (MT1A)], at 5.5 y (P < 9E-08). Gene set enrichment analysis indicated that top-ranked CpGs (P < 0.001) were annotated to genes enriched in neurodevelopmental biological processes. Corroborating these findings, DNAm at several top identified CpGs from the EWAS was associated with cortical surface area and IQ at 5.5 y (P < 0.05).
In-hospital percentage mother's milk intake by VLBW infants was associated with variations in DNAm of neurodevelopmental genes at 5.5 y; some of these DNAm variations are associated with brain structure and IQ.This trial was registered at isrctn.com as ISRCTN35317141 and at clinicaltrials.gov as NCT02759809.
极低出生体重(VLBW,<1500 克)婴儿母乳摄入与后期神经发育之间关联的机制尚不清楚。据推测,早期营养可能通过改变基因表达,通过表观遗传修饰来影响神经发育途径。胞嘧啶-鸟嘌呤二核苷酸(CpG)处的 DNA 甲基化(DNAm)变化是一种常用的表观遗传修饰。
我们旨在评估 VLBW 婴儿的早期母乳摄入量是否与 5.5 岁时的 DNAm 变化相关,以及这些变化是否与神经发育表型相关。
本队列研究是对加拿大安大略省出生的 VLBW 婴儿进行的 5.5 年随访(2016-2018 年),这些婴儿参加了捐赠母乳改善神经发育结局试验。我们进行了全基因组关联研究(EWAS),以测试住院期间母亲母乳喂养的百分比(不包括补充的捐赠母乳)是否与幼儿期(n=143;平均年龄±SD:5.7±0.2 岁;出生体重:1008±517 g)的口腔细胞中的 DNAm 相关。DNAm 使用 Illumina Infinium MethylationEPIC 阵列在 814,583 个 CpG 上进行评估。在二次分析中,我们测试了排名靠前的 CpG 与幼儿期神经发育的早期测量值(例如大脑皮质总面积[n=41,MRI]和全量表智商[n=133,韦氏学前和初级智力量表-IV])之间的关联。
EWAS 分析表明,VLBW 婴儿住院期间的母乳摄入量与 2 个 CpG 处的 DNAm 相关,cg03744440[肌球蛋白 XVB(MYO15B)]和 cg00851389[金属硫蛋白 1A(MT1A)],在 5.5 岁时(P<9E-08)。基因集富集分析表明,排名靠前的 CpG(P<0.001)被注释为富含神经发育生物学过程的基因。这些发现得到了证实,EWAS 中几个排名靠前的 CpG 的 DNAm 与 5.5 岁时的皮质表面积和智商相关(P<0.05)。
VLBW 婴儿住院期间的母乳摄入量百分比与 5.5 岁时神经发育基因的 DNAm 变化相关;其中一些 DNAm 变化与大脑结构和智商相关。这项试验在 isrctn.com 上注册为 ISRCTN35317141,在 clinicaltrials.gov 上注册为 NCT02759809。